insulin lispro

FDA Drug Profile — ADMELOG

insulin lispro is listed in the FDA National Drug Code directory with 5 NDC codes, marketed under brand name including ADMELOG. Available dosage form: injection, solution.

Drug details

Generic Name
insulin lispro
Brand Names
ADMELOG
Application Number
BLA209196
Sponsor
Sanofi-Aventis U.S. LLC
NDC Codes
5
Dosage Forms
INJECTION, SOLUTION
Routes
INTRAVENOUS, SUBCUTANEOUS
Active Ingredients
INSULIN LISPRO

Indications and Usage

1 INDICATIONS AND USAGE ADMELOG is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. ADMELOG is a rapid-acting human insulin analog indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.